ESR1 and intrahepatic cholangiocarcinoma: ICC patients have smaller tumors, less lymph node invasion, less distant metastasis rate, higher frequency of well tumor differentiation degree, higher ER positive and PR positive rates, and less chemotherapy and radiotherapy.